Physician
Smart Physician Systems PC
Smart Physician Systems PC was paid $6.32M by Medicaid between Jan 2018 and Dec 2024, across 30 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 30% of everything it billed.
33Billing provider infoSMART PHYSICIAN SYSTEMS PC
MICHIGAN CITY, IN 46360
MICHIGAN CITY, IN 46360
33aNPI1023550183assigned 11/07/2016
33bProvider typeInternal Medicine Physician
28Total paid$6.32M
24GClaims122,541
24DCodes billed30
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Indiana
Rank by total paid#15 of 316
Median peer was paid$17K
This provider vs. median374×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,056 | $101K | |
| 2019 | 10,440 | $645K | |
| 2020 | 21,054 | $728K | |
| 2021 | 23,702 | $1.12M | |
| 2022 | 21,738 | $1.36M | |
| 2023 | 20,995 | $1.26M | |
| 2024incomplete | 17,556 | $1.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 30% | 34,404 | 20,956 | $1.90M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 24% | 17,502 | 11,644 | $1.49M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 24,912 | 16,167 | $1.43M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.5% | 11,821 | 7,642 | $474K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.3% | 5,561 | 4,206 | $398K |
| 80348 | 2.0% | 4,836 | 2,878 | $128K | |
| 80362 | 2.0% | 4,838 | 2,877 | $127K | |
| 80354 | 1.9% | 4,516 | 2,681 | $120K | |
| 80365 | 1.7% | 3,972 | 2,393 | $105K | |
| 80373 | <1% | 2,128 | 1,349 | $51K | |
| 80361 | <1% | 1,542 | 1,016 | $30K | |
| 80305 | <1% | 4,030 | 2,084 | $26K |
18 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 107 | $9K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 195 | $9K |
| 99407 | <1% | 759 | $8K | |
| 90837 | Psychotherapy session, about an hour | <1% | 51 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 33 | $4K |
| 80372 | <1% | 383 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 185 | $1K |
| 20553 | <1% | 45 | $772.49 | |
| 80347 | <1% | 88 | $649.80 | |
| 80358 | <1% | 83 | $556.20 | |
| 80353 | <1% | 84 | $522.00 | |
| 80324 | <1% | 92 | $522.00 | |
| 96160 | <1% | 205 | $364.50 | |
| 96127 | <1% | 91 | $324.50 | |
| 81025 | <1% | 17 | $111.93 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $75.03 |
| 99401 | <1% | 18 | $36.22 | |
| 99000 | <1% | 27 | $11.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAJID, SYED (AUTHORIZED OFFICIAL)